跳至主要内容
临床试验/ISRCTN33222797
ISRCTN33222797终止未知

The McGill experience with Chronic Cough Treatment: A Phase 2 Pilot Study

McGill University Health Centre0 个研究点目标入组 100 人开始时间: 2015年1月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Included patients will be patients having had cough symptoms for at least 3 months (chronic cough), and that have already been worked up by respirologists to rule out other etiologies of cough. These patients will have failed all other medical therapies: inhaled corticosteroids and single dose of antireflux medication.

排除标准

  • 1. Patients without cough symptoms for over 3 months
  • 2. Patients that have not been worked up by a respirologist and who have not attempted inhaled corticosteroids or antireflux medication
  • 3. Patients who have been taking over the counter (OTC) antitussives, or angiotensin converting enzymes inhibitors medication
  • 4. Patients who have been taking antibiotics in the last month for a respiratory tract infection
  • 5. Patients who are smokers (both smoking and recent respiratory tract infection could confound our results)
  • 6. Patients who are pregnant or breast feeding
  • 7. Patients with abnormal hepatic or kidney function tests (creatinine over 100, ALT over 36 U/L, AST over 35 U/L, total bilirubin over 26 mmol/L)
  • 8. Patients with abnormalities on the electrocardiogram that have not been cleared by a cardiologist
  • 9. Patients with significant cardiac, renal, hepatic, epileptic, hematologic antecedents
  • 10. Patients taking anticholinergic or sympathomimetic medications
  • 11. Patients above the age of 70

研究者

相似试验